← Back to Search

Behavioural Intervention

Multi-disciplinary Care for Brain Cancer

N/A
Recruiting
Research Sponsored by University of Vermont Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must be able to complete questionnaires in English
Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms
Must not have
Patients who are < 18 years of age are not eligible
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at whether intensive multi-disciplinary care for patients with brain metastases is better than standard care at improving patient-reported symptoms and their awareness of their prognosis.

Who is the study for?
This clinical trial is for patients with brain metastases, which are cancerous tumors that have spread to the brain. Participants should be those who require a new approach to care and are currently receiving standard treatment.
What is being tested?
The study is testing whether an intensive multi-disciplinary care approach can improve patient-reported symptoms and awareness of their prognosis compared to standard care in individuals with brain metastases.
What are the potential side effects?
Since this is a health services intervention, it does not involve drugs or medical procedures, so traditional side effects are not expected. However, changes in care may affect emotional well-being or stress levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can complete questionnaires in English.
Select...
I have been newly diagnosed with brain metastases from a solid tumor.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient reported outcomes
Secondary study objectives
Feasibility
Patient understanding of prognosis
survival
Other study objectives
Exploratory survival outcome

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multidisciplinary CareExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of Vermont Medical CenterLead Sponsor
42 Previous Clinical Trials
25,805 Total Patients Enrolled
~21 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top